Company code 191351864
Žirmūnų str. 139A, Vilnius, Lithuania
E-mail: vvkt@vvkt.lt,
Phone: +370 5 263 92 64
Fax: +370 5 263 92 65








News title
Lithuania intends to take RMS role from UK in 70 MRP/DCP
2018-07-04

The United Kingdom (UK) submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union (EU). This means that The United Kingdom will then become a 'third country' from 30 March 2019. According to Directive 2001/83/EC the reference member state (RMS) can be only EU state. This means that RMS role in Mutual recognition and decentralised procedures (MRP/DCP) should be switched to other EU state.

--->
The Baltic meeting took place in Estonia
2018-05-24

The meeting of drug regulatory agencies of human and veterinary medicinal products of Baltic States took place on 10th of May 2018 in Tartu, Estonia. The aim of the meeting was to exchange information, to find new areas where we could promote Baltic strength based on our long cooperation and to harmonize the positions for different procedures in the area of regulation of medicinal products. Heads of Estonian, Latvian and Lithuanian agencies together with 40 specialists participated in the meeting. The organisations participating were Estonian State Agency of Medicines, Latvian State Agency of Medicines, Latvian Food and Veterinary Service, Lithuanian State Medicines Control Agency, Lithuanian National Food and Veterinary Risk Assessment Institute and Lithuanian State Food and Veterinary Service.

--->
Delegation from Poland paid an official visit to the Agency
2018-05-21

Representatives from Poland: Dr. Zbigniew J.  Król, the Vice Minister of the Ministry of Health, Dr. Roman Topór-Mądry,  the President of the Agency for Health Technology Assessment and Tariff System,  Dominik Dziurda, the Director of the Healthcare Services Department at the Agency for Health Technology Assessment and Tariff System, and Katarzyna Kędzior, the analyst from of the Healthcare Services Department at the Agency for Health Technology Assessment and Tariff System paid an official visit to Lithuanian State Medicines Control Agency (SMCA) on May 17.

--->
The additional risk minimisation measure for medicinal products
2018-05-18

During the Baltic Meeting held on 10th May 2018 in Tartu (Estonia) there was a discussion of Subgroup of common visual reminder (boxed warning and pictogram) to warn patient about teratogenic or foetotoxic effect on Baltic Package. The use, location and layout of the pictogram, also boxed warning issues were agreed.

--->
The fifth steering committee meeting has been organized
2018-05-11

On 19th April 2018, the fifth Steering Committee meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held to evaluate the results of the activities implemented within the project, as well as to set the main targets for the next quarter.

--->
Experts of the Medicines and Medical Devices Agency of the Republic of Moldova were trained in the gvp and gmp inspection process following the EU requirements for conducting and reporting of GVP and GMP inspections
2018-05-03

During 23-27April 2018, the third mission of the Study visit in respect of the Component 2 of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova (MMDA) as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was organized. 

--->
Experts of the Medicines and Medical Devices Agency of the Republic of Moldova were trained in the GDP inspection process following the EU requirements for conducting and reporting of GDP inspections
2018-04-05

During 25-31 March 2018, the second mission of the Study visit in respect of the Component 2 of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova (MMDA) as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was organized.

--->
Common agreement between the Netherlands and Lithuania will help to attract more medicinal products
2018-03-28

Representatives from the Netherlands Medicines Evaluation Board paid an official visit to Lithuanian State Medicines Control Agency on March 27-28. The purpose of the visit was to agree on implementation of the Agreement initiated by the Government of the Netherlands regarding medicinal products. The Agreement was signed by the Ministers of Health of the Netherlands and Lithuania.

--->
Regarding medicinal products for which „sunset clause“ may already be applied
2018-03-01

The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.

--->
The Fourth Steering Committee Meeting of the EU-funded Twinning project has been held
2018-01-23

On 11th January 2018, the fourth Steering Committee meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held to evaluate the results of the activities implemented within the project, as well as to set the main targets for 2018.

--->
The Third Steering Committee Meeting of the EU-funded Twinning project has been held
2017-10-25

On 12th October 2017, the third Steering Committee meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held for reviewing the progress made under the project.

--->
The Second Steering Committee Meeting of the EU-funded Twinning project has been held
2017-06-20

On 20th June 2017, the second Steering Committee meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held for reviewing the progress made under the project.

--->
The first Steering Committee of the EU-funded Twinning project has been held
2017-04-11

On April 4th, 2017, in Republic of Moldova the first Steering Committee Meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held for the purpose of reviewing the progress made under the project as well as to discuss results achieved and problems occurred. The Project Steering Committee also discussed the draft of the 1st Quarterly Report for the period 12 December 2016 – 31 March 2017.

--->
With EU support a new Twinning project in the area of medicines and medical devices is launched
2017-03-14

The formal opening ceremony organised on 9 March 2017 by the Delegation of the European Union to the Republic of Moldova, the Medicines and Medical Devices Agency of the Republic of Moldova, the State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania and the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of the Republic of Poland marked the official start of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” which will strive to improve the quality of the medicines, medical devices and pharmaceutical activity in the Republic of Moldova.

--->
Cardiovascular system medicines – the most consumed in all Baltic States
2016-10-26

The most consumed medicines in the Baltic States from 2013 to 2015 were medicines used to treat cardiovascular system diseases similar as during the period from 2010 to 2012, shows the new book “Baltic Statistics on Medicines 2013–2015”. The consumption of these medicines more than threefold exceeded the consumption of the second most used groups of medicines in each of the Baltic States (the group of alimentary tract and metabolism medicines in Latvia and Estonia and the nervous system medicines in Lithuania).

--->